Skip to main content
. 2021 Oct 31;61(3):387–400. doi: 10.1007/s40262-021-01071-5

Table 3.

Summary of baseline pathological covariates in subjects with NMOSD

Baseline variables Groups Counts
Aquaporin-4-antibody Seronegative 13
Seropositive 161
Expanded Disability Status Scale < 5 129
≥ 5 45
Number of prior NMOSD attacks < 2 25
≥2 149
Disease duration before diagnosis < 5 years 144
≥ 5 years 30

NMOSD neuromyelitis optica spectrum disorders